Pharma rejoins Medicines Australia

Gilead Sciences has returned to Medicines Australia as a Class 1 member, several years after leaving the industry body, saying the innovative medicines sector is strongest when it works together.

The decision comes at a time of significant change across healthcare systems globally, with increasing focus on how Australia can continue to recognise the value of innovation while ensuring patients have timely and equitable access to new treatments, the company said in a statement.

"Joining Medicines Australia strengthens our ability to improve access to innovative medicines,” Gilead ANZ General Manager, Arthur Miritis, added.

To see the whole article please log in.

Tiffany Walker

Log in with your member email for full access.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Email

Retype password

Not a member? Sign up here